Clinical Trial Update: Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a nasal gel to prevent nausea and vomiting associated with motion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Snippet

Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 3 | Status: COMPLETED